AOD-9604 FDA Approval History At a glance FDA approval status / Never approved for any indication in the United States NDA filing history / No New Drug Application has ever been submitted to FDA Chemical identity / Synthetic peptide corresponding to amino acids 176-191 of human growth hormone, with a tyrosine residue added at the C-terminus Developer / Metabolic Pharmaceuticals Ltd (Melbourne, Australia), now defunct Clinical trial outcome / Phase IIb trial (2007) failed to meet primary efficacy endpoint for obesity FDA compounding status / Placed on Category 2 list
"Glutathione Injection" is a "sulfonyl ethyl carbamoyl butanoic acid compound that's a highly effective inhibitor of autoimmune and inflammatory reactions"
Glutathione is a powerful antioxidant that can help protect you against free radical damage
The generation of oligodendroglial cells is preserved in the rostral migratory stream during aging
Notes: The compound has not been clinically tested, and any dosing suggestion is purely speculative
As an urban institution with strong roots in rural and tribal health, the college has graduated more than 1,000 physicians and matriculates 130 students each year
